SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Repligen Corp (RGEN)
An SI Board Since February 1996
Posts SubjectMarks Bans Symbol
395 38 0 RGEN
Emcee:  Rajiv Hargunani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
270Repligen Receives Approval for Clinical Trial of CTLA4-Ig in ITP Composition of nigel bates-4/18/2002
269RGEN News - FDA Approval FDA Grants Approval to Market SecreFlo(TM) for PancreaDavid Alan Cook-4/5/2002
268Interesting article in Wired this month on Aspergers / autism. (Not on line yet)nigel bates-11/23/2001
267Is anyone out there buying more at these depressed levels?? At this point I woulOuter-limits-7/1/2001
266Repligen Announces Extension of Phase 2 Clinical Trial of Secretin in Autism NEEScott H. Davis-6/18/2001
265Repligen Defines Biological Markers for Response to Secretin in Autism Three IndScott H. Davis-6/18/2001
264Volume today was 1901.82% of average daily volume. Looks like someone dumped 1.JMarcus-5/3/2001
263Company e-mail: I am writing to ask you to send an e mail to C-Span to request LLCF-4/24/2001
262Big move percentage wise on RGEN today (even with the DAQ down). Anyone have anyOuter-limits-4/20/2001
261Am J Pathol 2001 Mar;158(3):977-86 Related Articles, Books, LinkOut CD28-B7-mkeokalani'nui-4/17/2001
260Nat Immunol 2001 Jan;2(1):58-63 Related Articles, Books, LinkOut CTLA-4 up-rekeokalani'nui-4/17/2001
259Problem here is that the mechanism of action is not CNS related. Yet with a gooScott H. Davis-4/6/2001
258I told myself I would buy for ctla4Ig if secretin had trouble, but I can't skeokalani'nui-4/4/2001
257Reuters confirms my previous post: >>Repligen says autism drug misses maituck-4/4/2001
256I'm no expert, but it seems the trial design inadvertently led them to miss tuck-4/4/2001
255Any idea why the stock price would go down on this news? I thought the news looJMarcus-4/4/2001
254Results: >>Repligen Reports Positive Initial Results of Secretin Phase 2 tuck-4/4/2001
253Repligen to Report Initial Results of Phase 2 Clinical Trial Conference Call andScott H. Davis-4/3/2001
252I know its old (9/00), but this might be an interesting primer on ctla-4Ig. (Hekeokalani'nui-4/3/2001
251March 5 /PRNewswire/ -- Repligen Corporation (Nasdaq: RGEN - news) announced todnigel bates-3/27/2001
250Most unprofitable biotechs have been putrid. I'd really like to see the shoScott H. Davis-3/24/2001
249Any news on why RGEN took such a nasty hit today?? Time to buy more, or just looOuter-limits-3/13/2001
248Repligen Reports Third Quarter 2001 Results Company Updates Progress on ProductScott H. Davis-2/1/2001
247USA Today: usatoday.com A hope to dissolve autism's dark dreams LLCF-11/2/2000
246Ace, Thanks 4 the remainder. I followed David K. over here, started to do DD, Scott H. Davis-10/7/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News